Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

KRIT1 Antikörper (AA 471-585)

Dieses Kaninchen Polyklonal-Antikörper erkennt spezifisch KRIT1 in ELISA, IF und IHC. Er zeigt eine Reaktivität gegenüber Human.
Produktnummer ABIN7157699

Kurzübersicht für KRIT1 Antikörper (AA 471-585) (ABIN7157699)

Target

Alle KRIT1 Antikörper anzeigen
KRIT1 (KRIT1, Ankyrin Repeat Containing (KRIT1))

Reaktivität

  • 24
  • 20
  • 5
Human

Wirt

  • 35
  • 4
Kaninchen

Klonalität

  • 35
  • 4
Polyklonal

Konjugat

  • 16
  • 3
  • 3
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser KRIT1 Antikörper ist unkonjugiert

Applikation

  • 33
  • 16
  • 13
  • 13
  • 3
  • 3
  • 3
  • 1
ELISA, Immunofluorescence (IF), Immunohistochemistry (IHC)
  • Bindungsspezifität

    • 15
    • 6
    • 3
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    AA 471-585

    Kreuzreaktivität

    Human

    Aufreinigung

    >95%, Protein G purified

    Immunogen

    Recombinant Human Krev interaction trapped protein 1 protein (471-585AA)

    Isotyp

    IgG
  • Applikationshinweise

    Recommended dilution: IHC:1:500-1:1000, IF:1:200-1:500,

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Liquid

    Buffer

    Preservative: 0.03 % Proclin 300
    Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4

    Konservierungsmittel

    ProClin

    Vorsichtsmaßnahmen

    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Lagerung

    -20 °C,-80 °C

    Informationen zur Lagerung

    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • Target

    KRIT1 (KRIT1, Ankyrin Repeat Containing (KRIT1))

    Andere Bezeichnung

    KRIT1

    Hintergrund

    Background: Component of the CCM signaling pathway which is a crucial regulator of heart and vessel formation and integrity (By similarity). Negative regulator of angiogenesis. Inhibits endothelial proliferation, apoptosis, migration, lumen formation and sprouting angiogenesis in primary endothelial cells. Promotes AKT phosphorylation in a NOTCH-dependent and independent manner, and inhibits ERK1/2 phosphorylation indirectly through activation of the DELTA-NOTCH cascade. Acts in concert with CDH5 to establish and maintain correct endothelial cell polarity and vascular lumen and these effects are mediated by recruitment and activation of the Par polarity complex and RAP1B. Required for the localization of phosphorylated PRKCZ, PARD3, TIAM1 and RAP1B to the cell junction, and cell junction stabilization. Plays a role in integrin signaling via its interaction with ITGB1BP1, this prevents the interaction between ITGB1 and ITGB1BP1. Microtubule-associated protein that binds to phosphatidylinositol 4,5-bisphosphate (PIP2)-containing membranes in a GTP-bound RAP1-dependent manner. Plays an important role in the maintenance of the intracellular reactive oxygen species (ROS) homeostasis to prevent oxidative cellular damage. Regulates the homeostasis of intracellular ROS through an antioxidant pathway involving FOXO1 and SOD2. Facilitates the down-regulation of cyclin-D1 (CCND1) levels required for cell transition from proliferative growth to quiescence by preventing the accumulation of intracellular ROS through the modulation of FOXO1 and SOD2 levels.

    Aliases: Ankyrin repeat containing protein Krit1 antibody, CAM antibody, CCM 1 antibody, CCM1 antibody, Cerebral cavernous malformations 1 antibody, Cerebral cavernous malformations 1 protein antibody, Krev interaction trapped 1 antibody, Krev interaction trapped protein 1 antibody, KRIT 1 antibody, KRIT1 ankyrin repeat containing antibody, KRIT1 antibody, KRIT1_HUMAN antibody

    UniProt

    O00522

    Pathways

    Cell RedoxHomeostasis
Sie sind hier:
Chat with us!